Saturday, November 21, 2009 
|
|
|
| subscribe | manage account |
San Diego’s Top Influentials highlights the Who’s Who in San Diego business, profiling the top newsmakers of 2008. This year we focus on the leaders in Biotech, Tech & Defense; Construction; Finance; Law and Business & Consumer Services; and Real Estate.
Since 1886, The Daily Transcript has seen and reported on many significant changes to San Diego’s economic landscape, many of which stem from the remarkable ideas and contributions of individuals. We pay tribute to these prominent newsmakers — San Diego’s movers and shakers — with a special salute to the Top Influentials.
Since 1886, The Daily Transcript has seen and reported on many significant changes to San Diego’s economic landscape, many of which stem from the remarkable ideas and numerous contributions of single individuals. These individuals have impacted our lives, our communities, our economy. Now, we pay tribute to these prominent newsmakers – San Diego’s movers and shakers – with a special salute to the 120 Top Influentials.
As The Daily Transcript celebrates its 120th year in print, our editorial board -- with help from the San Diego Historical Society -- reflects back on our region’s rich history. In this feature, we pay tribute to some of the pioneers who played an integral part in laying the foundation for San Diego’s future growth. Read more about the contributions these individuals have made as the Transcript takes a brief look back through time.
In celebration of The Daily Transcript's 120th Anniversary, we pay tribute to the prominent business leaders -- past and present -- who have impacted the region. The Daily Transcript thanks its sponsors for participating in this anniversary publication.
9360 Towne Centre Dr., Suite 110
San Diego, CA 92121
Under Chief Executive Officer Ginger L. Graham, Amylin Pharmaceuticals has grown from a small company of 400 employees to more than 1,200. The company has evolved from a research-based biotech company into a fully commercial enterprise with two first-in-class medicines for diabetics, Symlin and Byetta.
Aside from her recent corporate achievements, Graham has also created a company culture that highlights community involvement. Under her leadership and direction, a Community Affairs office was created and staffed to ensure that Amylin supports local and other area initiatives that align with the company's mission. Graham has also been personally recognized as a role model for women and the biotechnology industry, and she continues to enrich the San Diego community by serving on a variety of distinguished boards, including the UCSD Health Sciences Advisory Board.